Coffee consumption has been shown to be associated with various health outcomes in observational studies. However, evidence for its association with epithelial ovarian cancer (EOC) is inconsistent and it is unclear whether these associations are causal.
common EOC subtype (12) . Whilst many individual studies have found conflicting directions of association with coffee consumption and EOC risk, subsequent meta-analysis studies found no evidence for an association (13) (14) (15) (16) (17) (18) . A more recent Danish study (19) suggested that moderate increase in daily caffeine intake (by one cup of coffee per day) might be protective against invasive EOC. Inconsistencies observed in the literature may be due to the lack of compatibility of categorical definitions (size of cup, content, caffeine intensity, method of brewing) and differences in definitions for baseline groups (i.e. non-drinkers). Some studies further combined consumption of tea and coffee to investigate caffeine intake specifically. However, more importantly, all studies to date examining the link between coffee/caffeine and EOC risk are observational studies where bias due to confounding may make it difficult to draw reliable conclusions (20) . For example, we can hypothesize that women diagnosed with EOC may have temporal nutritional awareness and develop aversion to caffeinated beverages (such as coffee and cola), which may distort the true underlying association in case-control studies. Since randomized trials examining coffee consumption in relation to ovarian risk have not been conducted, to work around these potential biases, we can apply an instrumental variable technique, Mendelian randomization (MR) (21) to draw causal inferences on coffee consumption.
Twin studies have shown that coffee consumption has a substantial genetic component, with an estimated heritability ranging from 0.37-0.77 (22) (23) (24) . This suggests that coffee consumption may be a suitable trait for MR studies. In this study we aim to refine the relationship between coffee and EOC susceptibility. We hypothesize that genetic predisposition towards higher coffee intake is inversely associated with i) overall EOC susceptibility and ii) high-grade serous EOC susceptibility, and draw inference on causality via MR.
Methods: Data source
Participants for this study were drawn from the Ovarian Cancer Association Consortium (OCAC).
Genotyping was performed using the customised Infinium OncoArray-500K array (Illumina) (25) consisting of~322 000 variants. OncoArray data were available for 59 115 samples across 71 study cohorts worldwide, of which 56 479 passed initial quality control protocols. Each individual was assigned values to indicate the proportion of European, African or Asian ancestry they inherited based on genetic makeup, using principal component analysis. These values sum up to 1 and are used to categorise the subjects into one of the intercontinental ancestry groups. Following that, imputation into the 1000 Genomes Project reference panel was carried out with pre-phasing using SHAPEIT and IMPUTE2 (26, 27) . First-degree related individuals and duplicated samples (n=1 732) were removed. DNA samples from women of non-European ancestry were excluded for this study.
The total sample size used in this study was 44 062 women of European ancestry ( Table 1 shows a breakdown of the sample size by EOC histology). Baseline characteristics of our study samples from OCAC according to weight, age, smoking status and other potential confounders are summarised in Supplementary Table 1 .
Genetic variants for the MR analyses were identified through an extensive review of published GWAS findings for coffee, tea and/or caffeine consumption (28) (29) (30) (31) (32) (33) . SNPs associated with coffee consumption (measured as cups/day) that were considered for use were rs1481012 in the ABCG2 gene, rs6968554 in the AHR gene, rs2470893 in the CYP1A2 gene, rs17685 in the POR gene and rs6265 in the BDNF gene. In our subsequent analysis, we investigated whether the association with coffee intake (in cups per day) onto ovarian cancer was driven mainly by genetic predisposition for altered caffeine intake. SNPs reported to show association with caffeine and considered for use here were rs6968865 from the AHR gene and rs2472297 from the CYP1A2 gene. All of the SNPs investigated were either directly genotyped or imputed with high quality (info-score > 0.9). Although these variants are different SNPs in AHR and CYP1A2, they are in high linkage-disequillibrium ‫ݎ(‬ ଶ =0.8), see discussion for more detail. In order to ensure that our SNPs of interest are strong instruments, we examined the statistical evidence in the literature for their association with coffee and with caffeine consumption respectively. The variance on coffee consumption explained by a particular SNP can be derived using ‫ݎ‬ ௌே 
Causal Effect estimation
To perform MR we utilised a two sample statistical model to estimate the magnitude of association between coffee consumption and ovarian cancer using summary statistics (34) . We fitted an additive model in SNPTEST (35) to test for association between each SNP and ovarian cancer status. Withinancestry principal components (PC1-PC9) were fitted to remove potential bias arising from intraethnic population difference. Additional covariates that might be confounders such as BMI, smoking status and alcohol consumption were not available for all the genotyped OCAC participants and hence were not included as covariates (although subject to the assumptions of MR, not including these potential confounders as covariates will not bias our results) to maximize sample size. The genomic control lambda value was computed using 483 972 SNPs genome-wide to assess the possibility of population stratification biasing the association between allele frequencies and phenotype.
For both coffee and caffeine consumption we used the Wald-type ratio estimator (36) to combine the SNP-estimates which uses the SNP-risk factor and SNP-cancer magnitude of association estimates to calculate the aggregated causal effect. We estimated a causal OR (COR) for all ovarian cancer and for the high grade serous subtype. High-grade serous was the only histological subtype with sufficient numbers for sub-set analysis.
Results: SNP Selection
We shortlisted a total of 4 independent SNPs (rs1481012, rs6968554, rs2470893, rs17685) as proxies for genetically determined coffee consumption behaviour (31) . For the analysis on caffeine, we used 2 SNPs (rs6968865,rs2472297) (33) as genetic proxies for total caffeine consumption per day (in mg). Each of these SNPs is robustly associated with p-values less than p<5 × 10 ି଼ for coffee consumption in the original coffee GWAS. Due to the smaller sample size in the published analysis for caffeine consumption, the published p-values for the effects of rs6968865 and rs2472297 on caffeine consumption were not as strong as those for the SNP-coffee associations but both of the SNPs combined associate with caffeine consumption with a p-value=3.74 × 10 ିଵସ (33), with its direction of association verified in an Australian sample (Supplementary A1). Each of the SNPs thus satisfies the strong MR instrument criterion (F>>10).
In our pleiotropy assessment, the SNP rs6265 in the BDNF gene was found to have pleiotropic effects on other traits of relevance to ovarian cancer (BMI and age of menarche, supplementary material) so it was excluded from our analyses. After removing BDNF, the 4 coffee SNPs combined explain about~1.2% of the variation in coffee intake (31) , whereas the 2 SNPs combined for our MR caffeine study explain about~1.3% of the variation in caffeine intake (33) . We also tested the association between established ovarian cancer risk factors (oral contraceptive use, estrogen use, parity) and
our SNPs of interest. The results of our pleiotropy assessment are available in Supplementary Table   3 (publicly available GWAS) and Supplementary Table 4 (OCAC dataset). In brief, no associations were found above chance level and we conclude that the assumptions of no-pleiotropy is not violated. In particular, coffee consumption and cigarette consumption are correlated in some populations but our chosen SNPs are not associated with smoking (Supplementary Table 3 ).
Instrumental variable analysis
The SNP-cancer association results for each genetic instrument used are available in Supplementary   Table 2 . We estimated the causal odds ratio associated with a genetically predicted one cup per day change in coffee consumption. For all EOC cases the COR for consuming one additional cup of coffee per day was 0.92 (95% confidence interval, CI: 0.79, 1.06). For high-grade serous EOC, the COR was 0.90 (95% CI: 0.73, 1.10). We also performed an additional analysis to investigate caffeine consumption, with the COR scaled in terms of an 80mg increase (the approximate caffeine content in a conventional cup of coffee). The COR for consuming an additional 80mg of caffeine was 1.01 (CI: 0.92, 1.11) for all EOC cases and 0.90 (CI: 0.73, 1.10) for high-grade serous. The CORs derived from individual SNP instruments are shown in Figure 1 for coffee consumption; and Figure 2 for caffeine intake.
Population Stratification and confounding
Due to the missing covariate data on some OCAC participants (see Supplementary Table 1 ), the analyses were performed by only fitting the first 9 genetic (ancestral) principal components as covariates. In a sensitivity analysis using participants with confounder data available (n~11 400), adjustment for potential confounders (age of menarche, education level, number of pregnancies, oral contraceptive use, estrogen use, smoking and BMI) did not change the magnitude of the SNPdisease associations (See Supplementary Table 6 ). The genomic control lambda was 1.076 (ߣ ଵ = 1.007, LD-score intercept=1.032) demonstrating that there is little evidence for inflation of the genome-wide association statistics due to population stratification. Plots of the ancestral principal components (PC1 against PC2) between cases and controls indicate that the cases and controls are homogeneous (See Supplementary Figure 1 and 2).
Discussion:
In our study sample of 44 062 European participants from OCAC, we found no evidence suggestive of a large causal association between (genetically predicted) coffee consumption and overall EOC risk nor on high-grade serous EOC. Similarly, our findings consistently suggest no causal link between caffeine intake and EOC susceptibility.
Research in context
Most epidemiological studies in the past investigated the association of EOC with coffee consumption by assessing the difference in EOC risk among non-coffee drinkers and strong coffee drinkers. Consumption of > 3 cups of coffee per day was used as a benchmark to indicate strong coffee drinking behaviour. To compare our results, we rescaled findings from these observational studies to reflect an averaged moderate change in daily coffee consumption (1 cup of coffee per day) using Equation 1 in Supplementary material. The resultant estimates from our study were broadly compatible with results of previous meta-analyses ( Figure 3 ).
Although some individual observational studies have found associations between coffee consumption and risk of EOC, meta-analyses have found no evidence to show that coffee consumption protects against EOC (13) . However, a common criticism of observational studies is inconsistency in the definition of categorised consumption (i.e. different studies adopt different definitions of heavy drinkers) and the variability in types of coffee beverages, which may differ strongly in terms of nutritional content (most importantly, caffeine). These systematic differences can make the interpretation of meta-analysed findings difficult. Moreover, it is difficult to rule out the potential effects of selection bias in case-control studies and of unmeasured or uncontrolled confounding in observational studies in general. In contrast, here we use genetically predicted coffee intake to provide more uniform estimates of coffee consumption in a large sample size (coffee GWAS (31), n>80 000). Our 2-sample MR design allows us to investigate the underlying association without the issue of potential confounders such as education level, alcohol use and smoking behaviour, which was established by earlier studies to be strongly correlated to coffee consumption.
In our pleiotropy assessment, the SNP instruments we employ are not associated with these potential confounders (Supplementary table 3 ).
Even though the MR analyses were performed separately for coffee consumption and caffeine intake with independent SNPs within each study, the inference we draw from these findings are not independent. This is due to the fact that, for each study the most important single SNPs (rs2470893 in CYP1A2 which explains~0.5% of the variance in coffee consumption (31) and rs2472297 in CYP1A2 which explains~0.8% of the variance in caffeine consumption (33) ) are in high linkage disequilibrium (r 2 =0.7 between the two SNPs). Hence, the effect of those SNPs (rs2470893, rs2472297) on coffee and caffeine consumption may not be separable (i.e. CYP1A2 is involved in metabolizing common bioactive compounds in coffee). The same applies for SNP rs6968865 and rs6968554 in AHR.
Previous studies have highlighted a potential role of caffeine in inducing p53-dependent (tumour suppression gene) apoptosis (37) . Since TP53 mutations are found in almost all high-grade serous EOC (38) , an analysis of high-grade serous alone was of particular interest. However in our study, coffee and caffeine intake did not appear to be associated with any risk of high-grade serous carcinoma among Europeans.
Strengths and limitations
One of the strength of our study is that participants used in our analyses were all of European ancestry, limiting potential bias due to population heterogeneity. Furthermore, the use of ancestral principal components to define ethnicity also prevents heritage-reporting errors (i.e. ethnicity was determined based on SNP profiles, as summarised by ancestry principal components to avoid selfreporting biases). In our MR study, the use of GWAS findings to predict coffee/caffeine consumption rather than relying on self-reports of consumption should remove misclassification biases that can plague self-reported studies and contribute to statistical heterogeneity in meta-analyses of observational studies. Since coffee consumption generally stabilizes during adulthood, our 2-sample MR approach is protected by potential biases due to apparent age differences between the SNPcoffee samples and the OCAC samples. In other words, the estimated SNP-coffee association during adulthood remain a robust genetic predisposition to lifetime coffee intake behaviour.
For our MR to infer about causality, several MR assumptions have to be met. Firstly, the instruments (SNPs) used here were robustly associated (with F>>10) to coffee and caffeine intake respectively.
Secondly, he SNPs used in this study showed no evidence for any pleiotropic effects that may confound the association with EOC susceptibility. The third MR assumption, that the genetic variants used in our study only influence EOC susceptibility through mediating coffee consumption, can be difficult to test directly. However, previous studies have examined the role of CYP1A1, CYP1A2 and AHR in detail (28, 29, 32, 39) . In each case, a SNP in or near the gene has been implicated by GWAS and we assume that the action of the SNP on coffee consumption is via the specified gene. Taking each in turn, CYP1A2 encodes the primary enzyme that metabolises caffeine in the liver, while CYP1A1 encodes protein that metabolises polycyclic aromatic hydrocarbons, which are more commonly found in coffee beans. The AHR gene is known to induce both CYP1A1 and CYP1A2 via a DNA binding mechanism (29) and is also responsible in detection of toxic chemicals (39) . Despite coffee intake being strongly correlated with smoking, our pleiotropy assessment indicated that none of the SNPs appear to be associated (Bonferroni corrected p-value > 0.05) with smoking behaviours.
Moreover, the lack of a main effect of the SNPs on smoking makes a coffee-smoking interaction less likely -Thus, it seems very improbable that these SNPs directly influence ovarian cancer through other independent biological processes.
Although we found no evidence supportive of an association between the SNPs used and common risk factors for EOC (40, 41)(e.g. smoking, oral contraceptive use, parity, etc.), it is hard to rule out directly possibilities of residual pleiotropy. However, suppose that a SNP has a strong pleiotropic effect which biases our results -for us to observe the null causal odds ratio we find here, the other SNPs (or some combination of SNPs) must act pleiotropically in the opposite direction and with similar magnitude to the first SNP. Since this is unlikely, it is unlikely that pleiotropic effects have a considerable influence on our non-causality conclusion.
There are some limitations that should also be considered in our analyses. Firstly, our study was performed using only European ancestry women and our findings may not generalize to other populations. Even though our SNPs greatly exceed the traditional strong instruments criteria (F>10), our SNPs combined only account for a relatively small proportion of variation (~1.2%) in coffee consumption (cups per day), potentially leading to problems in power when applying MR. With a relatively small proportion of variance explained, we must extrapolate from small changes in predicted coffee consumption. If the sample size in our data linking genotype to ovarian cancer risk were small, the overall estimates of the causal odds ratio would be too large to be useful. However, as we have available a large dataset from an international consortium, the overall standard error in our causal odds ratio is relatively small, allowing us to make clear statements on the likely limits of the causal effect of coffee consumption on ovarian cancer (e.g. for all histologies the causal OR is 0.92 with 95% confidence interval 0.79, 1.06).
The precision of our estimates is good for the most common subtype high grade serous (Causal OR 0.90 with 95% CI: 0.73, 1.10) but for the less common subtypes taken individually our power is low;
we similarly have insufficient power to perform stratified analyses (e.g. based on groups with particular smoking or BMI status).
The difference in coffee consumption as quantified in our MR analysis can be hard to interpret. In our analysis, CORs are calculated based on one additional cup of coffee per day averaging across all possible quantities of coffee consumption among regular coffee drinkers (including non-drinkers).
This made it difficult to compare our estimates reliably with those from studies that investigated extreme ends of the trait distribution (heavy coffee drinking (>5 cups) and/or coffee drinkers to nondrinkers). Here, it is difficult for our study to completely rule out previous findings that showed positive associations of EOC when comparing very heavy coffee-drinkers to other categories (13) .
That is, our findings only infer that moderate differences in coffee consumption (averaging over the entire trait distribution) do not influence risk of EOC as the MR framework assumes that modifiable exposures linearly affect the underlying risk factor; which might be violated if the outcome to exposure relationship is non-linear (follows a J-shaped curve).
An additional consideration is how to handle non-coffee drinkers. For caffeine this is not an issue because non-users are included in the SNP association studies. For coffee consumption, in our main analysis, we focus on "cups per day" coffee consumption. However, the GWASs to date on "cups per day" in coffee consumers also found (31) that the same SNPs were also strongly associated with drinking status ("high" versus "low/no" coffee consumption). Hence our findings in support of noncausality of "cups per day" probably extend to alternative definitions such as "high" versus "low/no" status.
We found no evidence indicative of a strong association between EOC risk and genetically predicted coffee or caffeine levels. However, our estimates were not statistically inconsistent with earlier observational studies and we were unable to rule out small protective associations. Our MR based results are more readily interpretable than previous observational studies because they are unlikely to be adversely affected by confounding biases which can invalidate the conclusions from observational studies.
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A1 Exploring the role of SNP instruments in caffeine consumption
It is important to note that the sample size of the genetic association study for caffeine intake (1) were much smaller than those in the published coffee GWAS. Although we opted to characterize the effect of our chosen instrumental variable SNPs on genetically predicted caffeine consumption using published data, we also confirmed the role these SNPs play using data on directly measured (self-reported) caffeine intake (through tea, cola, chocolate and coffee) from one of the studies participating in OCAC -2,347 participants from the Australian Ovarian Cancer Study (see Supplementary Table 5 ). The results for the caffeine SNPs (rs6968865 and rs2472297) were consistent with the published findings (1).
This serves as a validation of instrument strength, providing reassurance that the pattern of association of these SNPs is consistent across studies and that the results from our two-sample MR approach are robust (i.e. for the scenario where the SNP-caffeine associations come from a different sample than SNP-disease associations). The adjusted model is a logistic regression model on ovarian cancer status adjusted for 9 genetic principal components and covariates: education attainment, age at menarche, number of pregnancies, smoking, oral contraceptive use, estrogen use (and BMI in Set 2). The original model is a logistic model adjusted for only the 9 genetic principal components. The analysis on BMI is separated (reported in 7B) due to high number of missing values on BMI from the participants. 
